Key result
Global ischemic heart disease mortality fell ~23% from 2000 to 2019, despite persistent regional disparities.
Why the study?
Ischemic heart disease remains a leading cause of global morbidity and mortality, with persistent disparities based on sex and geographic region.
How did global and regional ischemic heart disease mortality rates change between 2000 and 2019?
Observational (n=2,253,000,000)
Yes
How did global and regional ischemic heart disease mortality rates change between 2000 and 2019?
Despite global declines in IHD mortality from 2000 to 2019, disparities persist with rising rates in Africa, Asia, and Central/South America highlighting a growing burden in low- and middle-income regions.
Declining global IHD mortality supports sustained prevention in high-income regions; leaves open drivers of rising burdens in Asia, Africa, and Latin America.
BACKGROUND: Ischemic heart disease (IHD) remains one of the leading causes of morbidity and mortality across the globe, and disparities exist based on sex and geographic region. OBJECTIVES: This study investigates global trends in IHD mortality and examines disparities based on sex and geographic regions. METHODS: IHD mortality data from 105 countries were obtained from the World Health Organization Mortality Database. Crude mortality rates (CMRs) and age-standardized mortality rates (ASMRs) per 100,000 individuals were calculated, with average annual percentage change (AAPC) analyzed using joinpoint regression. Regional and sex-specific trends were assessed using stratified analyses of CMR and ASMR. RESULTS: Globally, CMR declined from 138 per 100,000 (95% CI: 131-145) in 2000 to 106 per 100,000 (95% CI: 102-114) in 2019 (AAPC: -1.79, 95% CI: -1.93 to -1.66). Similarly, ASMR declined from 104 per 100,000 (95% CI: 99-108) to 65.5 (95% CI: 62-69) in 2019 per 100,000 (AAPC: -2.16, 95% CI: -2.13 to -2.20). Regionally, CMRs decreased in Oceania, Europe, and North America, while they rose in Asia, Africa, and Central and South America. ASMRs declined worldwide except in Africa (AAPC: 1.33, 95% CI: 1.30-1.36). Males showed higher mortality than females, but both sexes demonstrated decreasing trends, with males having a steeper decline. In age groups across all regions, Africa showed an upward trend, while other regions demonstrated declines. CONCLUSIONS: While global IHD mortality has declined from 2000 to 2019, disparities by geographic region and sex persist. Implementing targeted health awareness programs and collaborative global health efforts are crucial for addressing these inequalities.
No takes yet. Share an insight, caveat, or question.
Jaiswal et al. (2025) conducted an observational in Ischemic Heart Disease (IHD) mortality (n=2,253,000,000). Time period 2000 to 2019 (Epidemiological observation) vs. Year 2000 as baseline was evaluated on Global crude mortality rate (CMR) for ischemic heart disease per 100,000 individuals (AAPC -1.79, 95% CI -1.93 to -1.66). Global crude mortality rates for ischemic heart disease significantly declined from 138 per 100,000 in 2000 to 106 per 100,000 in 2019, though regional disparities persist.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: